Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Seminars in Oncology
|
December 21, 2006
Combined-modality strategy for gastrointestinal stromal tumors
Burton L Eisenberg
American Journal of Clinical Oncology
|
January 22, 2013
The SSG XVIII/AIO trial: results change the current adjuvant treatment recommendations for gastrointestinal stromal tumors
Burton L Eisenberg
Clinical Colorectal Cancer
|
November 15, 2006
Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials
Burton L Eisenberg
Oncology (Williston Park, N.Y.)
|
December 20, 2003
Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors
Burton L Eisenberg
Annals of Surgical Oncology
|
May 5, 2004
Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy
Burton L Eisenberg, Ian Judson
Expert Opinion on Pharmacotherapy
|
June 5, 2003
Pharmacotherapy of gastrointestinal stromal tumours
Burton L Eisenberg, Margaret von Mehren
International Journal of Cancer
|
June 15, 2011
Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors
Burton L Eisenberg, Jonathan C Trent
Cancer Chemotherapy and Pharmacology
|
December 1, 2010
Adjuvant and neoadjuvant therapy for primary GIST
Burton L Eisenberg, Kerrington D Smith
Hematology/Oncology Clinics of North America
|
November 3, 2012
Gastrointestinal stromal tumor--background, pathology, treatment
Burton L Eisenberg, J Marc Pipas
Surgical Oncology Clinics of North America
|
March 3, 2004
Intraoperative radiotherapy in the multimodality approach to bone and soft tissue cancers
Rodney J Ellis, Edward Kim, Timothy J Kinsella, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Seminars in Oncology
|
December 21, 2006
Combined-modality strategy for gastrointestinal stromal tumors
Burton L Eisenberg
American Journal of Clinical Oncology
|
January 22, 2013
The SSG XVIII/AIO trial: results change the current adjuvant treatment recommendations for gastrointestinal stromal tumors
Burton L Eisenberg
Clinical Colorectal Cancer
|
November 15, 2006
Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials
Burton L Eisenberg
Oncology (Williston Park, N.Y.)
|
December 20, 2003
Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors
Burton L Eisenberg
Annals of Surgical Oncology
|
May 5, 2004
Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy
Burton L Eisenberg, Ian Judson
Expert Opinion on Pharmacotherapy
|
June 5, 2003
Pharmacotherapy of gastrointestinal stromal tumours
Burton L Eisenberg, Margaret von Mehren
International Journal of Cancer
|
June 15, 2011
Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors
Burton L Eisenberg, Jonathan C Trent
Cancer Chemotherapy and Pharmacology
|
December 1, 2010
Adjuvant and neoadjuvant therapy for primary GIST
Burton L Eisenberg, Kerrington D Smith
Hematology/Oncology Clinics of North America
|
November 3, 2012
Gastrointestinal stromal tumor--background, pathology, treatment
Burton L Eisenberg, J Marc Pipas
Surgical Oncology Clinics of North America
|
March 3, 2004
Intraoperative radiotherapy in the multimodality approach to bone and soft tissue cancers
Rodney J Ellis, Edward Kim, Timothy J Kinsella, et al.
Page
of 4